Navigation Links
Study Spotlights a Natural Infection Fighter
Date:1/3/2008

The body produces its own hydrogen peroxide, but it must be kept in balance

THURSDAY, Jan. 3 (HealthDay News) -- The human body makes its own hydrogen peroxide --- the same disinfectant found in many first-aid kits and bathroom cabinets -- to help fight infections and keep cells healthy.

But when levels of hydrogen peroxide in the body get too high, this can endanger cell structures.

Now, researchers at Wake Forest University School of Medicine, in Winston-Salem, N.C., have released a detailed description of the way in which two proteins work together to keep hydrogen peroxide levels where they should be.

Writing in the Jan 3 issue of Nature, they describe the activity of a molecule called peroxiredoxin (Prx), which helps keep hydrogen peroxide levels below the amount that would cause damage to cellular structures. According to the researchers, Prx turns extra hydrogen peroxide into water, but when levels of the compound are very high, Prx starts calling on other proteins to help with the task.

"It basically acts as a sensor and warns the cell that levels are too high, and that the cell needs to respond," lead author Thomas J. Jonsson, a postdoctoral fellow at Wake Forest, said in a prepared statement. "Once that threat is gone, Prx needs to go back to its normal state."

The question the team wanted to answer was how Prx returned to its normal state. Previous research indicated that a protein called sulfiredoxin (Srx) participated in that process. The team used X-ray crystallography to understand how Srx worked with Prx. The technology allowed the team to capture the process in three dimensions.

What the research team found is a process they refer to as an "embrace": Prx unfolds, flips around and attaches itself to the back of Srx. That embrace creates a chemical reaction that repairs Prx.

According to the researchers, understanding the ways in which proteins work to keep cells h
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Carnegie Mellon study identifies where thoughts of familiar objects occur inside the human brain
2. American College of Physicians receives grant to study cost of patient-centered medical home
3. New study in the journal Sleep finds that catathrenia can be successfully treated with CPAP
4. Allergic reactions to gadolinium-based contrast agents are rare, study finds
5. LASIK works well, according to long-term study of highly myopic patients
6. Study Sheds Light on Origins of Sudden Cardiac Death
7. Study Spotlights Exercise-Friendly Day-Care Centers
8. Breast cancer gene mutation more common in Hispanic, young black women, Stanford/NCCC study finds
9. Study suggests some brain injuries reduce the likelihood of post-traumatic stress disorder
10. Kaiser Permanente -- Group Health study shows depression worsens HIV treatment
11. Most breast cancer surgeons dont talk to patients about reconstruction options, U-M study finds

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)...Newswire/ -- An exciting treatment gaining accepta...telet-rich plasma therapy (PRP), is showing strong...nt procedures, according to a prominent dental res...ology . ,, James Rutkowski, DMD, PhD, reporte...merican Academy of Implant Dentistry that platelet...
(Date:12/3/2009)...new cases created by a single case of H1N1 influen...ccination, social distancing and the use of antivi...he virus, suggests an epidemiological modelling st...7 reported in CMAJ ( Canadian Medical Associat... at data from laboratory-confirmed cases of H1N1 b...
(Date:12/3/2009)...i World Medical, a leading global healthcare compa...ce, announced that international medical quality a...cal Quality Advisory Board (MQAB). , ... –- Satori World Medical, a leading global h...ical travel space, announced that international me...
(Date:12/3/2009)...idue in those who rise and smoke, , , T...cigarette first thing in the morning? If so, take ... smoke inhale more nicotine than other smokers. ,... the researchers said he thinks it could be a sign...drags on their cigarettes. And that, he said, coul...
(Date:12/3/2009)...c. 3 To help children better under...o prevent contracting all forms of influenza, a ne...called Molly and the Flu . ,, The DVD was crea...er (ENAHEC), which is part of the Area Health Educ...tes. ,, The U.S. Centers for Disease Control an...
Breaking Medicine News(10 mins):Health News:Platelet-rich Plasma Enhances Bone and Tissue Growth for Dental Implants 2Health News:Vaccination, antivirals and social distancing may blunt impact of H1N1 influenza 2Health News:Former Chief Medical Officer of Joint Commission International Joins Satori World Medical's Medical Quality Advisory Board 2Health News:Former Chief Medical Officer of Joint Commission International Joins Satori World Medical's Medical Quality Advisory Board 3Health News:Former Chief Medical Officer of Joint Commission International Joins Satori World Medical's Medical Quality Advisory Board 4Health News:Early Morning Smokers May Be More Dependent on Nicotine 2Health News:New Animated DVD Helps Children to Better Understand and Prevent Contracting the Flu 2
... from Chongqing Bureau of Health, BLOOMINGTON, Mi...Education is hosting the first major medical,deleg...a. During their,three-month stay, the physicians w..."We,re honored that the Chongqing Bureau of Health...
...nchronized Slides at 5pm Today, LAWRENCE, Mass., ...leading manufacturer of innovative dialysis produc...irst quarter ended March 31,2008., Revenues for t...venues in the in-center market, from the Company,s...
...eart failure in those with Duchenne muscular dystr...- Patients with Duchenne muscular dystrophy often ...t or delay the onset of this condition, a new Cana...compound called cGMP, which relaxes smooth muscle....
...er influences are limiting the growth ..., May 12 Aon Corporation (NYSE: AOC ),the leadin...g services,today released an analysis of liability...Logo: http://www.newscom.com/cgi-bin/prnh/2004121...
...swire-FirstCall/ -- Tianyin,Pharmaceutical, Co., I...d,supplier of modernized traditional Chinese medic...ed that the Company will present at Roth Third,Ann... Guoqing, Jiang, Tianyin,s Chairman and CEO, Mr. A...
...th,Services, Inc. (Nasdaq: GTIV ), the nation,s l...ces, announced today that it is scheduled to,prese...21, 2008 at the 2008,Citi Investment Research Glob..., http://investors.gentiva.com/events.cfm to regi...
Other Medicine News:Health News:First Major Chinese Medical Delegation Visits Minnesota 2Health News:NxStage Medical Reports First Quarter 2008 Results 2Health News:NxStage Medical Reports First Quarter 2008 Results 3Health News:NxStage Medical Reports First Quarter 2008 Results 4Health News:NxStage Medical Reports First Quarter 2008 Results 5Health News:NxStage Medical Reports First Quarter 2008 Results 6Health News:NxStage Medical Reports First Quarter 2008 Results 7Health News:NxStage Medical Reports First Quarter 2008 Results 8Health News:NxStage Medical Reports First Quarter 2008 Results 9Health News:NxStage Medical Reports First Quarter 2008 Results 10Health News:NxStage Medical Reports First Quarter 2008 Results 11Health News:Viagra May Protect Hearts of Some Muscular Dystrophy Patients 2Health News:Aon Study Finds Stability in Nationwide Liability Costs in the Long Term Health Care Sector 2Health News:Aon Study Finds Stability in Nationwide Liability Costs in the Long Term Health Care Sector 3Health News:Tianyin Pharmaceutical to Present at Roth Third Annual China Discovery Tour in Beijing on May 20, 2008 at 12:40 p.m. Beijing Time 2Health News:Gentiva(R) Health Services to Present May 21 at 2008 Citi Investment Research Global Health Care Conference in New York 2Health News:Gentiva(R) Health Services to Present May 21 at 2008 Citi Investment Research Global Health Care Conference in New York 3
(Date:12/3/2009)... Stryker Corporation (NY...ctors has authorized the Company to repurchase up ...timing and amount of any purchases will be determi...luation of market conditions, stock price and othe...erations. Purchases may be made from time to time...
(Date:12/3/2009)...c. 3 Decision Resources, one of ...cusing on pharmaceutical and healthcare issues, fo...azil will grow from $417 million in 2008 to $834 m...owth rate is attributed to a growing prevalent and...eration antidiabetics such as Merck,s Januvia, Nov...
(Date:12/3/2009)... 3 Honeywell (NYSE: HON ) announ... Pro-Lab Laboratuar Teknolojileri, which will dist...h-purity solvents in Turkey. ,, Burdick & J...ogy and pharmaceutical companies in the drug disco...wth rate of the Turkish pharmaceutical market is e...
Breaking Medicine Technology:Stryker Announces $750 Million Share Repurchase Program and Declares a $0.15 Per Share Quarterly Dividend 2Brazil's Type 2 Diabetes Drug Market Will Grow to $834 Million by 2013 2Brazil's Type 2 Diabetes Drug Market Will Grow to $834 Million by 2013 3Honeywell and Pro-Lab Sign Distribution Agreement for Laboratory Chemicals in Turkey 2Honeywell and Pro-Lab Sign Distribution Agreement for Laboratory Chemicals in Turkey 3Positive trend for diabetic eye health 3B AMD may predict heart disease 3B vision impacts life success 58726 1Positive trend for diabetic eye health 3B AMD may predict heart disease 3B vision impacts life success 58726 2Positive trend for diabetic eye health 3B AMD may predict heart disease 3B vision impacts life success 58726 3Duke Singapore scientists find new way to classify gastric cancers 58725 1Duke Singapore scientists find new way to classify gastric cancers 58725 2New Tools Help Emergency Planners Select Alternate Care Facilities and Transfer Patients During Disasters 58720 1New Tools Help Emergency Planners Select Alternate Care Facilities and Transfer Patients During Disasters 58720 2
...ne 3 Delcath Systems, Inc.,(Nasdaq: DCTH ) annou...thlehem, PA, part of St. Luke,s Hospital & Health ...I clinical trial for the treatment of,inoperable m...s,Percutaneous Hepatic Perfusion (PHP) System for ...r agent melphalan. This Phase III multi-center,stu...
...ed at ASCO Show 26% Partial Response, 63% Clinical... HAYWARD, Calif., June 3 Kosan Biosciences,Incorp...ead Hsp90 inhibitor,tanespimycin, demonstrated a h... when administered in combination with trastuzumab...astatic breast cancer whose disease had,either pro...
Other Medicine Technology:Delcath Expands Phase III Trial for Metastatic Melanoma to Include St. Luke's Cancer Center 2Delcath Expands Phase III Trial for Metastatic Melanoma to Include St. Luke's Cancer Center 3Kosan's Lead Hsp90 Inhibitor, Tanespimycin, Shows High Level of Activity in Trastuzumab Resistant/Refractory HER2-Positive Breast Cancer in a Phase 2 Trial 2Kosan's Lead Hsp90 Inhibitor, Tanespimycin, Shows High Level of Activity in Trastuzumab Resistant/Refractory HER2-Positive Breast Cancer in a Phase 2 Trial 3Kosan's Lead Hsp90 Inhibitor, Tanespimycin, Shows High Level of Activity in Trastuzumab Resistant/Refractory HER2-Positive Breast Cancer in a Phase 2 Trial 4Kosan's Lead Hsp90 Inhibitor, Tanespimycin, Shows High Level of Activity in Trastuzumab Resistant/Refractory HER2-Positive Breast Cancer in a Phase 2 Trial 5Kosan's Lead Hsp90 Inhibitor, Tanespimycin, Shows High Level of Activity in Trastuzumab Resistant/Refractory HER2-Positive Breast Cancer in a Phase 2 Trial 6
PVA, The Personal Vision Assistant
...elco general purpose incubators designed to provid...equired for the most demanding incubation applicat...cubators feature push-button temperature setpoint ...ilt-in over-temperature protection. Equally import...
...ecision Economy Incubators available in five diffe...on; capacities of 1.4 cu. Ft. (39 liters), 2.5 cu....ually important, Precision Economy Incubators comb...ature sensitivity, stability, and uniformity. As a...
40D Large
Medicine Products: